Product
SG1827
1 clinical trial
1 indication
Indication
CancerClinical trial
A Phase I Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SG1827 in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-28